Uric acid stones

Nephrology

Volumn 12, Issue SUPPL. 1, 2007, Pages

  Becker, Gavin ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALKALI; ALLOPURINOL; BICARBONATE; CITRATE POTASSIUM; HYDROCHLOROTHIAZIDE;

CALCIUM STONE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LITHOTRIPSY; METABOLIC SYNDROME X; PATIENT COMPLIANCE; PRIORITY JOURNAL; RADIOLOGY; RECURRENT DISEASE; REVIEW; ULTRASOUND; URIC ACID STONE; URINE PH; URINE VOLUME;

EID: 33846988919     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00774.x     Document Type: Review

References (21)

1. Baker PW, Coyle P, Bais R, Rofe AM. Influence of season, age, and sex on renal stone formation in South Australia. Med. J. Aust. 1993; 159: 390-2.
2. Federle MP, McAninch JW, Kaiser JA et al. Computed tomography of urinary calculi. AJR Am. J. Roentgenol. 1981; 136: 255-8.
3. Resnick MI, Kursh ED, Cohen AM. Use of computerized tomography in the delineation of uric acid calculi. J. Urol. 1984; 131: 9-10.
4. Chu G, Rosenfield AT, Anderson K et al. Sensitivity and value of digital CT scout radiography for detecting ureteral stones in patients with ureterolithiasis diagnosed on unenhanced CT. AJR Am. J. Roentgenol. 1999; 173: 417-23.
5. Nakada SY, Hoff DG, Attai S et al. Determination of stone composition by noncontrast spiral computed tomography in the clinical setting. Urology 2000; 55: 816-19.
6. Smith RC, Verga M, Dalrymple N et al. Acute ureteral obstruction: Value of secondary signs of helical unenhanced CT. AJR Am. J. Roentgenol. 1996; 167: 1109-13.
7. Pollack HM, Arger PH, Goldberg BB et al. Ultrasonic detection of nonopaque renal calculi. Radiology 1978; 127: 233-7.
8. Pak CY, Poindexter JR, Adams-Huet B et al. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am. J. Med. 2003; 115: 26-32.
9. Millman S, Strauss AL, Parks JH et al. Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis. Kidney Int. 1982; 22: 366-70.
10. Pak CY, Poindexter JR, Peterson RD et al. Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis. Urology 2002; 60: 789-94.
11. Gutman AB, Yu TF. Uric acid nephrolithiasis. Am. J. Med. 1968; 45: 756-79.
12. Pak CY, Sakhaee K, Fuller C. Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int. 1986; 30: 422-8.
13. Rodman JS. Prophylaxis of uric acid stones with alternate day doses of alkaline potassium salts. J. Urol. 1991; 145: 97-9.
14. Sharma SK, Indudhara R. Chemodissolution of urinary uric acid stones by alkali therapy. Urol. Int. 1992; 48: 81-6.
15. Moran ME, Abrahams HM, Burday DE et al. Utility of oral dissolution therapy in the management of referred patients with secondarily treated uric acid stones. Urology 2002; 59: 206-10.
16. Anderson EE, Rundles RW, Silberman HR et al. Allopurinol control of hyperuricosuria: A new concept in the prevention of uric acid stones. J. Urol. 1967; 97: 344-7.
17. De Vries A, Frank M, Liberman UA et al. Allopurinol in the prophylaxis of uric acid stones. Ann. Rheum. Dis. 1966; 25: 691-3.
18. Blechman WJ, Rosenberg DG, Hilf P. Use of allopurinol in gout, hyperuricemia and uric acid lithiasis. South. Med. J. 1967; 60: 215-18.
19. Sakhaee K, Adams-Huet B, Moe OW et al. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int. 2002; 62: 971-9.
20. Abate N, Chandalia M, Cabo-Chan AV et al. The metabolic syndrome and uric acid nephrolithiasis: Novel features of renal manifestation of insulin resistance. Kidney Int. 2004; 65: 386-92.
21. Maalouf NM, Sakhaee K, Parks JH et al. Association of urinary pH with body weight in nephrolithiasis. Kidney Int. 2004; 65: 1422-5.